| NCT Number | NCT03967808 |
| Lead Sponsor | Central Hospital, Nancy, France
Collaborators: Agence de La Biomédecine |
| Conditions | End-stage Renal Disease |
| Enrollment | 6,000 participants |
| Start Date | 2001-01 |
| Primary Completion | 2050-12 (estimated) |
| Study Completion | 2050-12 (estimated) |
| Updated on ClinicalTrials.gov | 2021-07-28 |